Here are four things to know.
1. A bill introduced by Assemblyman Wood would make it unlawful to distribute prescription drug coupons when there is a less expensive equivalent that approved by the Food and Drug Administration available, according to the article.
2. His goal with the bill is to control health costs.
3. Assemblyman Wood advocated for the bill by saying drug coupons are used as a “marketing tool to drive patients to higher-priced drugs,” and that using prescription drug coupons drives up the cost of health insurance premiums, reports California Healthline.
4. However, the article states, the Pharmaceutical Research and Manufacturers of America, a Washington, D.C.-based trade association, recently defended prescription drug coupons in a paper, saying they help “patients access needed medicines at reduced prices.”
For more on this story, read Pauline Bartolone‘s full report in California Healthline.
More articles on supply chain:
US representative pushes legislation to curb drug prices: 5 things to know
Study: Amgen’s Repatha lowers risk of heart problems
Government subpoenas Biogen over MS drug prices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
